{
  "title": "Biotech Investor Intelligence Suite",
  "description": "Comprehensive analytics for investment decisions in clinical-stage biotech companies",
  "version": "1.0",
  "created": "2025-04-14",
  "persona": "investor",
  "categories": ["Portfolio Analysis", "Risk Assessment", "Market Analysis", "Valuation"],
  "files": [
    "investor_portfolio_overview.pdf",
    "therapeutic_area_success_rates.pdf",
    "pipeline_valuation_models.pdf",
    "biotech_risk_calculator.pdf",
    "market_landscape_analysis.pdf",
    "trial_success_probability.pdf",
    "competitor_pipeline_assessment.pdf",
    "catalysts_timeline.pdf"
  ],
  "features": [
    {
      "name": "Portfolio Strength Assessment",
      "description": "AI-driven analysis of clinical pipeline strength with probabilistic success modeling",
      "icon": "chart-bar"
    },
    {
      "name": "Risk-Adjusted NPV Modeling",
      "description": "Trial-specific risk adjustment for accurate net present value calculations",
      "icon": "calculator"
    },
    {
      "name": "Competitive Intelligence",
      "description": "Comprehensive landscape analysis with differentiation scoring",
      "icon": "users"
    },
    {
      "name": "Catalyst Monitoring",
      "description": "Predictive timeline of major value-inflecting events",
      "icon": "calendar"
    },
    {
      "name": "Regulatory Success Prediction",
      "description": "FDA and EMA approval probability based on historical patterns",
      "icon": "check-circle"
    }
  ],
  "quickStats": {
    "successPredictionAccuracy": 92,
    "analyticsDatapoints": 178540,
    "historicalTrials": 3021,
    "regulatoryApprovals": 872,
    "biomarkerInsights": 1255
  }
}